. "Libritabs"@en . . "Chlordiazepoxide binds to stereospecific benzodiazepine (BZD) binding sites on GABA (A) receptor complexes at several sites within the central nervous system, including the limbic system and reticular formation. This results in an increased binding of the inhibitory neurotransmitter GABA to the GABA(A) receptor.BZDs, therefore, enhance GABA-mediated chloride influx through GABA receptor channels, causing membrane hyperpolarization. The net neuro-inhibitory effects result in the observed sedative, hypnotic, anxiolytic, and muscle relaxant properties."@en . . "7-chloro-2-Methylamino-5-phenyl-3H-1,4-benzodiazepin-4-oxide"@en . "Multum"@en . . " "@en . . . . . . . . . . . . . . . "Clopoxide"@en . "approved"@en . "Helogaphen"@en . . . . "Chlordiazepoxide base"@en . . . . . . . . . . . . . . . . . . . . . . . . . . . . . "Humans and other mammals"@en . . . "Sternbach, L.H.; US. Patent 2,893,992; July 7,1959; assigned to Hoffmann-LaRoche, Inc."@en . . . . " "@en . . . . . . . . . . "CDP"@en . . . . . . . . . . . . . "Chloradiazepoxide"@en . . . "An anxiolytic benzodiazepine derivative with anticonvulsant, sedative, and amnesic properties. It has also been used in the symptomatic treatment of alcohol withdrawal. [PubChem]"@en . . . . . . . . . . . . . . . "Silibrin"@en . . "Chlordiazepoxide is excreted in the urine, with 1% to 2% unchanged and 3% to 6% as conjugate."@en . . "Take without regard to meals."@en . . . . . "Avoid alcohol."@en . . "Tropium"@en . . . . . . . . "# Skerritt JH, Johnston GA: Enhancement of GABA binding by benzodiazepines and related anxiolytics. Eur J Pharmacol. 1983 May 6;89(3-4):193-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/6135616 # Oishi R, Nishibori M, Itoh Y, Saeki K: Diazepam-induced decrease in histamine turnover in mouse brain. Eur J Pharmacol. 1986 May 27;124(3):337-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/3089825 # Earley JV, Fryer RI, Ning RY: Quinazolines and 1,4-benzodiazepines. LXXXIX: Haptens useful in benzodiazepine immunoassay development. J Pharm Sci. 1979 Jul;68(7):845-50. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/458601 # Olive G, Dreux C: [Pharmacologic bases of use of benzodiazepines in pereinatal medicine] Arch Fr Pediatr. 1977 Jan;34(1):74-89. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/851373 # Vozeh S: [Pharmacokinetic of benzodiazepines in old age] Schweiz Med Wochenschr. 1981 Nov 21;111(47):1789-93. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/6118950"@en . "Chlordiazepoxidum"@en . . "illicit"@en . "Risolid"@en . "58-25-3"@en . . . "Chlordiazepoxide"@en . . . . . . . . . . . "For the management of anxiety disorders or for the short-term relief of symptoms of anxiety, withdrawal symptoms of acute alcoholism, and preoperative apprehension and anxiety."@en . . "LD₅₀=537 mg/kg (Orally in rats). Signs of overdose include respiratory depression, muscle weakness, somnolence (general depressed activity)."@en . . . . . . "Methaminodiazepoxide"@en . . . . "24-48 hours"@en . . . .